Welcome to ViroMed Laboratories

Home Page - Slider

Cord Blood Testing
Reproductive (IVF) Testing
Tissue and Eye Bank Testing
Bone Marrow and Stem Cell Testing
Cord Blood Testing

ViroMed offers comprehensive infectious disease testing for cord blood donors. In addition to infectious disease marker (IDM) testing, ViroMed performs product sterility testing for cord blood collections. 

Reproductive (IVF) Testing

Donations of reproductive tissues (including oocytes, semen, and embryos) are tested in accordance with the FDA Code of Federal Regulations (21 CFR 1271) and current FDA guidance.

Tissue and Eye Bank Testing

ViroMed has a national reputation for expertise in the tissue donor industry. We have earned customer trust though more than a decade of service in the tissue donor industry.

Bone Marrow and Stem Cell Testing

Recently awarded a National Marrow Donor Program® contract for IDM testing, ViroMed performs infectious disease testing for donors of hematopoietic stem/progenitor cells, including minimally manipulated bone marrow and peripheral blood stem cells.

ViroMed Laboratories Highlights

West Nile Virus NAT Testing

In September 2016, the FDA issued a new guidance document that addresses the intent to reduce the risk of transmission of West Nile Virus (WNV) from living donors of HCT/Ps and recommends the use of an FDA-licensed NAT to test living donors for evidence of active infection with WNV. For facilities within the United States (all 50 states and the District of Columbia), WNV-NAT testing is recommended on HCT/Ps recovered from June 1st through October 31st every year. Read more

HTLV I/II Supplemental Testing

ViroMed will begin using the MP Diagnostics HTLV Blot 2.4 test kit for HTLV I/II supplemental testing beginning May 9, 2016. This kit is currently the only FDA-licensed test on the market for use as a supplemental test to confirm the presence of anti-HTLV I/II antibodies in serum or plasma. Additionally, this kit will differentiate between HTLV type-1 and HTLV type-2 infections.

FDA Guidance

To ensure compliance with the new FDA guidance document entitled Use of Donor Screening Tests to Test Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products for Infection with Treponema pallidum (Syphilis), ViroMed Laboratories will no longer offer the Rapid Plasma Reagin (RPR) test alone or reflexed to the Fluorsecent Treponemal Antibody tests (FTA-ABS) assay (tests 139278 and 139425). We will continue to offer the CAPTIA™ Syphilis (T pallidum)-G assay (139280). Read more..

Test Methodology Change

ViroMed Laboratories is making a change to its test offerings for Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Types 1 and 2 on September 29, 2015. Tests on living donor samples will be performed using the Abbott Diagnostics PRISMnEXT (PRISM) system.  The test methodology for samples from cadaveric tissue donors will not change. Client letters explaining this change have been mailed.